(Press-News.org) Chicago, Illinois (Embargoed until 9:30 am, CDT, Monday, June 26, 2023)—Umar Mahmood, MD, PhD, chief of Nuclear Medicine and Molecular Imaging, director of the Center for Precision Imaging, and associate chair for imaging sciences in the Department of Radiology at Massachusetts General Hospital and professor of radiology at Harvard Medical School in Boston, Massachusetts, has been named as the first recipient of the new Minoshima-Pappas Transformational Leadership Award. Mahmood was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting.
The Minoshima-Pappas Transformational Leadership Award was created to recognize an individual who has made transformative impact in the field and elevated the value of nuclear medicine and molecular imaging. Award recipients will have initiated, developed, and successfully implemented unique and significant transformative value within the field of nuclear medicine and molecular imaging.
For more than two decades, Mahmood has been involved in the development and implementation of new imaging methods for the examination of disease processes, with a focus on translatable technology and early therapeutic response assessment. A prolific researcher, his work has helped guide precision medicine, specifically his research on the early phases of translation of new radiopharmaceuticals and novel applications of approved agents to develop and improve disease characterization.
“In addition to the outstanding research that Dr. Mahmood has conducted over the course of his career, what most stands out is his dedication to mentoring up-and-coming nuclear medicine professionals and his commitment to giving back to the field,” said Satoshi Minoshima, MD, PhD, FSNMMI. “In his work and by his example, Dr. Mahmood embodies the true spirit of the Minoshima-Pappas Transformational Leadership Award.”
Mahmood received a bachelor’s degree from the California Institute of Technology in Pasadena, California, and earned his medical and doctoral degrees from Weil Cornell Medical College in New York, New York. He performed doctoral and post-doctoral work at Memorial Sloan Kettering Cancer Center and completed his radiology residency at Massachusetts General Hospital.
Mahmood has held many volunteer leadership positions throughout the course of his career. At SNMMI, Mahmood served on the board of directors, as Scientific Program Committee chair, on the Center for Molecular Imaging Innovation & Translation (CMIIT) board, and on the Commission on Education. He was also a member of multiple SNMMI committees and task forces, including the Future Tracers Task Force, Continuing Education Committee, and Education Committee, among others. Mahmood was also a Highlights lecturer at the SNMMI Annual Meeting. He has served as chair of the Board of Scientific Counselors of the Clinical Center of the National Institutes of Health. Currently, Mahmood serves on the Radiological Society of North America board of directors as secretary/treasurer, on the International Society of Radiology executive committee, and on the Academy of Radiology & Biomedical Imaging Research executive committee.
“It is a truly profound honor to be chosen as the first recipient of the SNMMI Minoshima-Pappas Transformational Leadership Award,” said Mahmood. “Satoshi Minoshima and Virginia Pappas have had a foundational role over many decades in shaping the field of nuclear medicine as we practice it today. To have this award bestowed on me is both wonderful and humbling. I am grateful for the privilege to contribute to the science that drives patient care; for the many bright, creative, and hardworking individuals I have mentored who lead the field and will ably guide us into the future; and the opportunity I have had in working collaboratively with nuclear medicine thought leaders from around the globe in my leadership roles at SNMMI to jointly advance the field I care so deeply about.
The Minoshima-Pappas awards was named for Satoshi Minoshima, MD, PhD, SNMMI past president, and Virginia Pappas, CAE, SNMMI chief executive officer. In 2017, Minoshima and Pappas launched the SNMMI Value Initiative, a strategic vision and roadmap to advance the crucial role of nuclear medicine and molecular imaging to the medical community, regulators, patients, and the public. Through the Value Initiative, the SNMMI was able to change the dynamics of the field, and the Minoshima-Pappas Transformational Leadership Award recognizes individuals who do the same.
###
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
END
Umar Mahmood, MD, PhD, receives first annual SNMMI Minoshima-Pappas Transformational Leadership Award
2023-06-26
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Peter J. H. Scott, PhD, receives SNMMI Sam Gambhir Trailblazer Award
2023-06-26
Chicago, Illinois (Embargoed until 9:30 am, CDT, Monday, June 26, 2023)—Peter J. H. Scott, PhD, associate professor of radiology and pharmacology, division director of nuclear medicine, and director of the PET Center at the University of Michigan in Ann Arbor, Michigan, has been named as the 2023 recipient of the Sam Gambhir Trailblazer Award. Scott was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting.
Scott's nuclear medicine and molecular imaging research spans ...
Act now to prevent uncontrolled rise in carbon footprint of computational science, say Cambridge scientists
2023-06-26
Cambridge scientists have set out principles for how computational science – which powers discoveries from unveiling the mysteries of the universe to developing treatments to fight cancer to improving our understanding of the human genome, but can have a substantial carbon footprint – can be made more environmentally sustainable.
Writing in Nature Computational Science, researchers from the Department of Public Health and Primary Care at the University of Cambridge argue that the scientific community needs to act now if it is to ...
Study of Earth’s stratosphere reduces uncertainty in future climate change
2023-06-26
New research led by the University of East Anglia (UEA) reduces uncertainty in future climate change linked to the stratosphere, with important implications for life on Earth.
Man-made climate change is one of the greatest challenges facing us today, but uncertainty in the exact magnitude of global change hampers effective policy responses.
A significant source of uncertainty relates to future changes to water vapour in the stratosphere, an extremely dry region of the atmosphere 15–50 km above the Earth’s surface.
Future increases in water vapour here risk amplifying climate change and slowing down the recovery ...
New study reveals brain's potential to regulate fentanyl consumption, offering hope in the fight against opioid addiction
2023-06-26
The opioid crisis continues to pose a grave public health concern, with synthetic opioids such as fentanyl posing a major risk for development of addiction and death due to overdose. In a ground-breaking development, a recent study by the research group led by Prof. Ami Citri at the Hebrew University of Jerusalem's Edmond and Lily Safra Center for Brain Sciences has unveiled crucial insights into the brain's potential ability to regulate the urge to consume fentanyl. This discovery offers a glimmer of hope in the ongoing battle against ...
Supplemental Nutrition Assistance Program access and racial disparities in food insecurity
2023-06-26
About The Study: Racial disparities in food insecurity were found among low-income households that do not participate in Supplemental Nutrition Assistance Program (SNAP) but not among those that do, suggesting that access to SNAP should be improved. These results also highlight the need to examine the structural and systemic racism in food systems and in access to food assistance that may contribute to disparities.
Authors: Laura J. Samuel, Ph.D., R.N., of the Johns Hopkins School of Nursing in Baltimore, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.20196)
Editor’s ...
Study of deep-sea corals reveals ocean currents have not fuelled rise in atmospheric carbon dioxide
2023-06-26
Pioneering analysis of deep-sea corals has overturned the idea that ocean currents contributed to increasing global levels of carbon dioxide in the air over the past 11,000 years.
The study, led by the University of Bristol in the UK and Nanjing University in China, examined historic deep-sea corals to shed intriguing new light on the history of ocean chemistry.
Understanding what has led to the pre-industrial rise in carbon dioxide (CO2) levels during the Holocene period, which dates back some 11,700 years to the present day, is a source of scientific debate. One theory suggests the increase in physical ...
Tuning T cell traits and functions with biomechanical materials
2023-06-26
By Benjamin Boettner
(Boston) — The successful campaign of adoptive T cell therapies, a type of immunotherapy in which immune T cells are collected from a patient, enhanced outside of the body, and reinfused back into the same patient, especially against blood cancers is well under way. But improving the ability to create patient-specific T cell populations with specific traits and functions could broaden clinicians’ repertoire of T cell therapies.
One way to approach this goal is to better understand how T cells’ traits and functions, including their cytotoxic effects on ...
New understanding of why kidney cancers become metastatic discovered by MD Anderson researchers
2023-06-26
HOUSTON ― Researchers at The University of Texas MD Anderson Cancer have engineered a new model of aggressive renal cell carcinoma (RCC), highlighting molecular targets and genomic events that trigger chromosomal instability and drive metastatic progression.
The study, published today in Nature Cancer, demonstrates that the loss of a cluster of interferon receptor (IFNR) genes plays a pivotal role in allowing cancer cells to become tolerant of chromosomal instability. This genomic feature may be used to help clinicians predict a tumor’s potential to become metastatic and treatment resistant.
Researchers led by Luigi Perelli, ...
Dry days trigger leaves to send a surprising growth signal telling roots to keep growing
2023-06-26
Scientists at the Sainsbury Laboratory Cambridge University (SLCU) have discovered a new molecular signalling pathway, triggered when leaves are exposed to low humidity, that ensures plant roots keep growing towards water.
In dry soil conditions, plants take action to try and conserve water by producing the drought stress hormone abscisic acid (ABA). For decades plant scientists thought that in response to dry soil, ABA was made in the roots and then transported to the leaves. In this root-to-shoot signalling pathway, ABA closes microscopic leaf pores, called stomata, to prevent water loss from leaves. In recent years, scientists ...
Study on rare antibodies hints at strategy tweaks that may future-proof COVID-19 vaccines
2023-06-26
New research examining how frequently our bodies produce broadly neutralizing antibodies (bnAbs) capable of thwarting a range of SARS-CoV-2 variants offers clues on the strategy tweaks that could potentially future-proof COVID-19 vaccines.
To counter invading viruses, our body deploys specific antibodies, among them the neutralizing kind targeting the receptor-binding domain (RBD) — the “Velcro hooks” used by pathogens to fasten onto our cells. As SARS-CoV-2 accumulates genetic mutations, new variants emerge donning sneaky disguises to outsmart our defenses. So-called bnAbs are elite neutralizing antibodies that can keep up ...